GENEVA, April 5 -- SHANGHAI INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 201/202/203/204, Building 1, No.720 Cailun Road, (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 201203), 上海银诺医药技术有限公司 (中国上海市浦东新区(上海)自由贸易试验区蔡伦路720弄1号楼201、202、203、204室) filed a patent application (PCT/CN2025/123189) for "NPQ-IGG2/FC FUSION PROTEIN AND USE THEREOF" on Sep 23, 2025. With publication no. WO/2026/067374, the details related to the patent application was ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.